Cameroon
Hepatitis B
Download HBV dataPrevalence of chronic HBV (HBsAg+)
National
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 4.22 (3.81 - 4.55) | 2019 | Modelled | IHME |
| 4.45 (4 - 4.75) | 2018 | Modelled | IHME |
| 4.59 (4.09 - 4.93) | 2017 | Modelled | IHME |
| 4.64 (4.14 - 4.98) | 2016 | Modelled | IHME |
| 4.69 (4.14 - 5.06) | 2015 | Modelled | IHME |
| 4.78 (4.21 - 5.16) | 2014 | Modelled | IHME |
| 4.91 (4.35 - 5.31) | 2013 | Modelled | IHME |
| 5.06 (4.53 - 5.49) | 2012 | Modelled | IHME |
| 5.21 (4.71 - 5.64) | 2011 | Modelled | IHME |
| 5.35 (4.88 - 5.77) | 2010 | Modelled | IHME |
| 5.46 (5.07 - 5.80) | 2009 | Modelled | IHME |
| 5.57 (5.25 - 5.84) | 2008 | Modelled | IHME |
| 5.68 (5.43 - 5.90) | 2007 | Modelled | IHME |
| 5.8 (5.60 - 5.98) | 2006 | Modelled | IHME |
| 5.92 (5.76 - 6.08) | 2005 | Modelled | IHME |
| 6.09 (5.94 - 6.22) | 2004 | Modelled | IHME |
| 6.29 (6.14 - 6.43) | 2003 | Modelled | IHME |
| 6.49 (6.32 - 6.67) | 2002 | Modelled | IHME |
| 6.66 (6.46 - 6.87) | 2001 | Modelled | IHME |
| 6.75 (6.53 - 6.99) | 2000 | Modelled | IHME |
| 6.79 (6.58 - 7.01) | 1999 | Modelled | IHME |
| 6.82 (6.60 - 7.04) | 1998 | Modelled | IHME |
| 6.84 (6.62 - 7.06) | 1997 | Modelled | IHME |
| 6.86 (6.64 - 7.09) | 1996 | Modelled | IHME |
| 6.9 (6.67 - 7.13) | 1995 | Modelled | IHME |
| 6.95 (6.73 - 7.18) | 1994 | Modelled | IHME |
| 7.04 (6.81 - 7.27) | 1993 | Modelled | IHME |
| 7.14 (6.91 - 7.39) | 1992 | Modelled | IHME |
| 7.27 (7.02 - 7.53) | 1991 | Modelled | IHME |
| 7.4 (7.13 - 7.68) | 1990 | Modelled | IHME |
| 8.3 (6.50 - 10.20) | 2017 | Survey/reported | Cameroon Population-based HIV Impact Assessment (CAMPHIA) 2017, 2020 |
| 4.43 (3.49 - 5.73) | 2015 | Modelled | WHO |
| 6.8 (6.50 - 7.40) | 2016 | Modelled | Razavi-Shearer et al, 2018 |
| 12.24 (11.71 - 12.78) | 2013 | Modelled | Schweitzer et al, 2015 |
Showing out of
Show more
Children under-5 years
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 1.02 (0.84 - 1.22) | 2019 | Modelled | IHME |
| 1.11 (0.89 - 1.29) | 2018 | Modelled | IHME |
| 1.2 (0.95 - 1.38) | 2017 | Modelled | IHME |
| 1.29 (1.02 - 1.48) | 2016 | Modelled | IHME |
| 1.37 (1.10 - 1.59) | 2015 | Modelled | IHME |
| 1.43 (1.16 - 1.65) | 2014 | Modelled | IHME |
| 1.48 (1.19 - 1.70) | 2013 | Modelled | IHME |
| 1.52 (1.23 - 1.75) | 2012 | Modelled | IHME |
| 1.56 (1.26 - 1.80) | 2011 | Modelled | IHME |
| 1.61 (1.27 - 1.86) | 2010 | Modelled | IHME |
| 1.65 (1.33 - 1.88) | 2009 | Modelled | IHME |
| 1.68 (1.39 - 1.90) | 2008 | Modelled | IHME |
| 1.71 (1.44 - 1.92) | 2007 | Modelled | IHME |
| 1.76 (1.51 - 1.96) | 2006 | Modelled | IHME |
| 1.82 (1.58 - 2.02) | 2005 | Modelled | IHME |
| 2.21 (1.96 - 2.42) | 2004 | Modelled | IHME |
| 3.01 (2.67 - 3.32) | 2003 | Modelled | IHME |
| 3.96 (3.52 - 4.38) | 2002 | Modelled | IHME |
| 4.76 (4.20 - 5.30) | 2001 | Modelled | IHME |
| 5.15 (4.51 - 5.75) | 2000 | Modelled | IHME |
| 5.21 (4.62 - 5.81) | 1999 | Modelled | IHME |
| 5.25 (4.70 - 5.86) | 1998 | Modelled | IHME |
| 5.28 (4.74 - 5.87) | 1997 | Modelled | IHME |
| 5.32 (4.77 - 5.94) | 1996 | Modelled | IHME |
| 5.36 (4.79 - 6.01) | 1995 | Modelled | IHME |
| 5.42 (4.88 - 6.06) | 1994 | Modelled | IHME |
| 5.49 (4.94 - 6.12) | 1993 | Modelled | IHME |
| 5.57 (4.98 - 6.21) | 1992 | Modelled | IHME |
| 5.65 (5 - 6.34) | 1991 | Modelled | IHME |
| 5.75 (4.96 - 6.49) | 1990 | Modelled | IHME |
| 1.9 (1.34 - 2.61) | 2015 | Modelled | WHO |
Showing out of
Show more
Number of people living with chronic HBV
National
Download| Value | Year | Type | Source |
|---|---|---|---|
| 768,890 (740,695 - 798,519) | 1990 | Modelled | IHME |
| 781,401 (754,541 - 809,594) | 1991 | Modelled | IHME |
| 795,785 (770,155 - 822,747) | 1992 | Modelled | IHME |
| 812,606 (786,550 - 839,395) | 1993 | Modelled | IHME |
| 832,610 (806,122 - 860,122) | 1994 | Modelled | IHME |
| 856,628 (829,004 - 885,248) | 1995 | Modelled | IHME |
| 884,666 (856,822 - 914,251) | 1996 | Modelled | IHME |
| 915,552 (886,858 - 945,518) | 1997 | Modelled | IHME |
| 948,267 (918,817 - 978,759) | 1998 | Modelled | IHME |
| 981,681 (950,744 - 1,013,530) | 1999 | Modelled | IHME |
| 1,014,460 (981,255 - 1,049,770) | 2000 | Modelled | IHME |
| 1,039,600 (1,008,960 - 1,072,480) | 2001 | Modelled | IHME |
| 1,053,830 (1,026,420 - 1,082,670) | 2002 | Modelled | IHME |
| 1,061,730 (1,036,990 - 1,086,050) | 2003 | Modelled | IHME |
| 1,068,730 (1,043,510 - 1,092,190) | 2004 | Modelled | IHME |
| 1,081,180 (1,051,040 - 1,110,230) | 2005 | Modelled | IHME |
| 1,099,620 (1,063,140 - 1,133,880) | 2006 | Modelled | IHME |
| 1,119,340 (1,070,010 - 1,161,850) | 2007 | Modelled | IHME |
| 1,139,330 (1,073,620 - 1,194,680) | 2008 | Modelled | IHME |
| 1,158,390 (1,075,270 - 1,229,860) | 2009 | Modelled | IHME |
| 1,175,120 (1,073,870 - 1,267,700) | 2010 | Modelled | IHME |
| 1,186,160 (1,072,860 - 1,283,400) | 2011 | Modelled | IHME |
| 1,191,500 (1,065,940 - 1,292,340) | 2012 | Modelled | IHME |
| 1,195,010 (1,059,210 - 1,293,820) | 2013 | Modelled | IHME |
| 1,201,130 (1,059,250 - 1,297,390) | 2014 | Modelled | IHME |
| 1,214,970 (1,073,210 - 1,312,560) | 2015 | Modelled | IHME |
| 1,239,700 (1,106,470 - 1,331,210) | 2016 | Modelled | IHME |
| 1,262,120 (1,125,740 - 1,356,310) | 2017 | Modelled | IHME |
| 1,258,380 (1,131,290 - 1,343,820) | 2018 | Modelled | IHME |
| 1,227,480 (1,107,980 - 1,324,080) | 2019 | Modelled | IHME |
| 1,605,000 (1,523,000 - 1,740,000) | 2016 | Modelled | Razavi-Shearer et al, 2018 |
Showing out of
Show more
HBV-related death rate
National
Download| Value (per 100,000) | Year | Type | Source |
|---|---|---|---|
| 7.19 (4.82 - 10.30) | 2019 | Modelled | IHME |
| 7.28 (4.88 - 10.40) | 2018 | Modelled | IHME |
| 7.41 (4.99 - 10.40) | 2017 | Modelled | IHME |
| 7.51 (5.08 - 10.60) | 2016 | Modelled | IHME |
| 7.69 (5.21 - 10.70) | 2015 | Modelled | IHME |
| 8.1 (5.49 - 11.40) | 2014 | Modelled | IHME |
| 8.54 (5.83 - 11.80) | 2013 | Modelled | IHME |
| 8.99 (6.12 - 12.30) | 2012 | Modelled | IHME |
| 9.48 (6.47 - 12.80) | 2011 | Modelled | IHME |
| 9.87 (6.76 - 13.20) | 2010 | Modelled | IHME |
| 10.1 (7.05 - 13.40) | 2009 | Modelled | IHME |
| 10.4 (7.27 - 13.80) | 2008 | Modelled | IHME |
| 10.8 (7.68 - 14.20) | 2007 | Modelled | IHME |
| 11.3 (8.03 - 14.80) | 2006 | Modelled | IHME |
| 11.7 (8.17 - 15.40) | 2005 | Modelled | IHME |
| 12.1 (8.44 - 16) | 2004 | Modelled | IHME |
| 12.6 (8.82 - 17.50) | 2003 | Modelled | IHME |
| 13.1 (9.09 - 19.20) | 2002 | Modelled | IHME |
| 13.3 (9.28 - 19.80) | 2001 | Modelled | IHME |
| 13.4 (9.30 - 19.50) | 2000 | Modelled | IHME |
| 13.3 (9.40 - 19.10) | 1999 | Modelled | IHME |
| 13.4 (9.34 - 19.10) | 1998 | Modelled | IHME |
| 13.4 (9.35 - 18.90) | 1997 | Modelled | IHME |
| 13.3 (9.31 - 18.80) | 1996 | Modelled | IHME |
| 13.3 (9.30 - 18.80) | 1995 | Modelled | IHME |
| 13.4 (9.28 - 19) | 1994 | Modelled | IHME |
| 13.4 (9.41 - 19.20) | 1993 | Modelled | IHME |
| 13.4 (9.39 - 19.10) | 1992 | Modelled | IHME |
| 13.4 (9.34 - 19.30) | 1991 | Modelled | IHME |
| 13.5 (9.37 - 19.60) | 1990 | Modelled | IHME |
Showing out of
Show more
HBV-related deaths
National
Download| Value | Year | Type | Source |
|---|---|---|---|
| 2,092 (1,402 - 2,987) | 2019 | Modelled | IHME |
| 2,060 (1,382 - 2,930) | 2018 | Modelled | IHME |
| 2,038 (1,373 - 2,870) | 2017 | Modelled | IHME |
| 2,006 (1,358 - 2,844) | 2016 | Modelled | IHME |
| 1,993 (1,351 - 2,769) | 2015 | Modelled | IHME |
| 2,035 (1,381 - 2,855) | 2014 | Modelled | IHME |
| 2,079 (1,420 - 2,878) | 2013 | Modelled | IHME |
| 2,118 (1,441 - 2,891) | 2012 | Modelled | IHME |
| 2,158 (1,473 - 2,915) | 2011 | Modelled | IHME |
| 2,171 (1,485 - 2,905) | 2010 | Modelled | IHME |
| 2,146 (1,496 - 2,842) | 2009 | Modelled | IHME |
| 2,132 (1,486 - 2,814) | 2008 | Modelled | IHME |
| 2,137 (1,513 - 2,790) | 2007 | Modelled | IHME |
| 2,149 (1,523 - 2,814) | 2006 | Modelled | IHME |
| 2,138 (1,492 - 2,814) | 2005 | Modelled | IHME |
| 2,124 (1,483 - 2,804) | 2004 | Modelled | IHME |
| 2,135 (1,489 - 2,960) | 2003 | Modelled | IHME |
| 2,136 (1,477 - 3,111) | 2002 | Modelled | IHME |
| 2,085 (1,449 - 3,086) | 2001 | Modelled | IHME |
| 2,016 (1,397 - 2,928) | 2000 | Modelled | IHME |
| 1,929 (1,359 - 2,763) | 1999 | Modelled | IHME |
| 1,870 (1,299 - 2,657) | 1998 | Modelled | IHME |
| 1,794 (1,252 - 2,533) | 1997 | Modelled | IHME |
| 1,719 (1,201 - 2,423) | 1996 | Modelled | IHME |
| 1,657 (1,155 - 2,335) | 1995 | Modelled | IHME |
| 1,602 (1,111 - 2,280) | 1994 | Modelled | IHME |
| 1,552 (1,086 - 2,217) | 1993 | Modelled | IHME |
| 1,495 (1,046 - 2,122) | 1992 | Modelled | IHME |
| 1,445 (1,005 - 2,081) | 1991 | Modelled | IHME |
| 1,400 (973 - 2,039) | 1990 | Modelled | IHME |
| 3,567 | 2016 | Modelled | WHO |
Showing out of
Show more
Percent of liver cancer deaths attributable to HBV
National
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 49 (41 - 58) | 2019 | Modelled | IHME |
| 49 (41 - 58) | 2018 | Modelled | IHME |
| 49 (40 - 58) | 2017 | Modelled | IHME |
| 49 (41 - 58) | 2016 | Modelled | IHME |
| 49 (41 - 58) | 2015 | Modelled | IHME |
| 50 (41 - 59) | 2014 | Modelled | IHME |
| 50 (42 - 59) | 2013 | Modelled | IHME |
| 51 (42 - 59) | 2012 | Modelled | IHME |
| 51 (43 - 60) | 2011 | Modelled | IHME |
| 52 (43 - 60) | 2010 | Modelled | IHME |
| 52 (43 - 60) | 2009 | Modelled | IHME |
| 52 (43 - 60) | 2008 | Modelled | IHME |
| 52 (43 - 60) | 2007 | Modelled | IHME |
| 52 (43 - 60) | 2006 | Modelled | IHME |
| 52 (43 - 60) | 2005 | Modelled | IHME |
| 52 (43 - 61) | 2004 | Modelled | IHME |
| 52 (43 - 61) | 2003 | Modelled | IHME |
| 52 (43 - 61) | 2002 | Modelled | IHME |
| 53 (44 - 61) | 2001 | Modelled | IHME |
| 53 (44 - 61) | 2000 | Modelled | IHME |
| 53 (44 - 61) | 1999 | Modelled | IHME |
| 53 (44 - 61) | 1998 | Modelled | IHME |
| 52 (44 - 61) | 1997 | Modelled | IHME |
| 52 (44 - 61) | 1996 | Modelled | IHME |
| 52 (43 - 61) | 1995 | Modelled | IHME |
| 52 (43 - 61) | 1994 | Modelled | IHME |
| 52 (43 - 61) | 1993 | Modelled | IHME |
| 51 (43 - 60) | 1992 | Modelled | IHME |
| 51 (43 - 60) | 1991 | Modelled | IHME |
| 51 (42 - 60) | 1990 | Modelled | IHME |
Showing out of
Show more
Coverage of 3-dose hepatitis B vaccine
Infants
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 79 | 2018 | Survey/reported | WHO/UNICEF |
| 86 | 2017 | Survey/reported | WHO/UNICEF |
| 85 | 2016 | Survey/reported | WHO/UNICEF |
| 84 | 2015 | Survey/reported | WHO/UNICEF |
| 87 | 2014 | Survey/reported | WHO/UNICEF |
| 89 | 2013 | Survey/reported | WHO/UNICEF |
| 85 | 2012 | Survey/reported | WHO/UNICEF |
| 82 | 2011 | Survey/reported | WHO/UNICEF |
| 84 | 2010 | Survey/reported | WHO/UNICEF |
| 80 | 2009 | Survey/reported | WHO/UNICEF |
| 84 | 2008 | Survey/reported | WHO/UNICEF |
| 82 | 2007 | Survey/reported | WHO/UNICEF |
| 81 | 2006 | Survey/reported | WHO/UNICEF |
| 79 | 2005 | Survey/reported | WHO/UNICEF |
| 67 | 2019 | Survey/reported | WHO/UNICEF |
Showing out of
Show more
Number of needles/syringes per PWID per year
People who inject drugs (PWID)
Download| Value | Year | Type | Source |
|---|---|---|---|
| 0 (0 - 0) | 2016 | Survey/reported | Harm Reduction International, 2016 |
Percent of PWID accessing OST
People who inject drugs (PWID)
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 0 | 2016 | Survey/reported | Harm Reduction International, 2016 |
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
No
Eligible for HBV generic medicines
Hepatitis C
Download HCV dataPrevalence of chronic HCV (RNA+/cAg)
National
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 2.62 (2.10 - 3.31) | 2019 | Modelled | IHME |
| 2.63 (2.10 - 3.32) | 2018 | Modelled | IHME |
| 2.63 (2.11 - 3.32) | 2017 | Modelled | IHME |
| 2.63 (2.12 - 3.31) | 2016 | Modelled | IHME |
| 2.64 (2.12 - 3.31) | 2015 | Modelled | IHME |
| 2.66 (2.15 - 3.34) | 2014 | Modelled | IHME |
| 2.71 (2.18 - 3.39) | 2013 | Modelled | IHME |
| 2.76 (2.21 - 3.47) | 2012 | Modelled | IHME |
| 2.8 (2.25 - 3.52) | 2011 | Modelled | IHME |
| 2.83 (2.27 - 3.57) | 2010 | Modelled | IHME |
| 2.83 (2.28 - 3.55) | 2009 | Modelled | IHME |
| 2.83 (2.29 - 3.53) | 2008 | Modelled | IHME |
| 2.83 (2.29 - 3.53) | 2007 | Modelled | IHME |
| 2.83 (2.30 - 3.53) | 2006 | Modelled | IHME |
| 2.83 (2.30 - 3.52) | 2005 | Modelled | IHME |
| 2.84 (2.31 - 3.53) | 2004 | Modelled | IHME |
| 2.86 (2.33 - 3.56) | 2003 | Modelled | IHME |
| 2.89 (2.36 - 3.59) | 2002 | Modelled | IHME |
| 2.93 (2.38 - 3.65) | 2001 | Modelled | IHME |
| 2.98 (2.41 - 3.71) | 2000 | Modelled | IHME |
| 3.08 (2.50 - 3.79) | 1999 | Modelled | IHME |
| 3.26 (2.66 - 3.96) | 1998 | Modelled | IHME |
| 3.46 (2.86 - 4.16) | 1997 | Modelled | IHME |
| 3.65 (3.03 - 4.35) | 1996 | Modelled | IHME |
| 3.8 (3.13 - 4.50) | 1995 | Modelled | IHME |
| 3.9 (3.23 - 4.61) | 1994 | Modelled | IHME |
| 3.99 (3.31 - 4.70) | 1993 | Modelled | IHME |
| 4.07 (3.37 - 4.81) | 1992 | Modelled | IHME |
| 4.14 (3.41 - 4.90) | 1991 | Modelled | IHME |
| 4.18 (3.43 - 4.97) | 1990 | Modelled | IHME |
| 0.7 (0.50 - 0.80) | 2015 | Modelled | Blach et al, 2017 |
Showing out of
Show more
Women of childbearing age (15–49 years)
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 0.6 (0.42 - 0.67) | 2019 | Modelled | Dugan et al., 2021 |
Prevalence of anti-HCV
Number of people living with chronic HCV (RNA+/cAg)
National
Download| Value | Year | Type | Source |
|---|---|---|---|
| 434,473 (356,652 - 515,972) | 1990 | Modelled | IHME |
| 444,813 (366,970 - 526,729) | 1991 | Modelled | IHME |
| 453,539 (374,887 - 536,096) | 1992 | Modelled | IHME |
| 460,792 (381,848 - 543,090) | 1993 | Modelled | IHME |
| 466,802 (386,549 - 551,615) | 1994 | Modelled | IHME |
| 471,831 (388,768 - 559,592) | 1995 | Modelled | IHME |
| 471,327 (390,988 - 561,521) | 1996 | Modelled | IHME |
| 463,411 (383,000 - 556,497) | 1997 | Modelled | IHME |
| 452,933 (370,471 - 550,614) | 1998 | Modelled | IHME |
| 445,586 (361,177 - 547,609) | 1999 | Modelled | IHME |
| 447,976 (361,766 - 557,999) | 2000 | Modelled | IHME |
| 458,270 (372,256 - 570,730) | 2001 | Modelled | IHME |
| 469,952 (383,868 - 582,299) | 2002 | Modelled | IHME |
| 483,338 (393,852 - 601,198) | 2003 | Modelled | IHME |
| 498,782 (406,276 - 620,492) | 2004 | Modelled | IHME |
| 516,666 (419,392 - 643,263) | 2005 | Modelled | IHME |
| 536,436 (435,417 - 669,096) | 2006 | Modelled | IHME |
| 557,112 (451,820 - 696,146) | 2007 | Modelled | IHME |
| 578,390 (468,429 - 722,680) | 2008 | Modelled | IHME |
| 599,902 (483,643 - 752,037) | 2009 | Modelled | IHME |
| 621,212 (499,198 - 784,073) | 2010 | Modelled | IHME |
| 638,404 (513,007 - 802,402) | 2011 | Modelled | IHME |
| 649,798 (521,510 - 816,165) | 2012 | Modelled | IHME |
| 658,607 (530,012 - 825,866) | 2013 | Modelled | IHME |
| 668,510 (539,372 - 839,626) | 2014 | Modelled | IHME |
| 683,747 (548,895 - 859,477) | 2015 | Modelled | IHME |
| 703,682 (566,826 - 883,863) | 2016 | Modelled | IHME |
| 723,991 (580,811 - 912,217) | 2017 | Modelled | IHME |
| 743,658 (594,089 - 940,765) | 2018 | Modelled | IHME |
| 762,824 (609,754 - 962,146) | 2019 | Modelled | IHME |
| 164,000 (117,000 - 184,000) | 2015 | Modelled | Blach et al, 2017 |
Showing out of
Show more
Women of childbearing age (15–49 years)
Download| Value | Year | Type | Source |
|---|---|---|---|
| 37,400 (26,500 - 41,900) | 2019 | Modelled | Dugan et al., 2021 |
HCV-related death rate
National
Download| Value (per 100,000) | Year | Type | Source |
|---|---|---|---|
| 0.93 (0.58 - 1.43) | 2019 | Modelled | IHME |
| 0.95 (0.59 - 1.46) | 2018 | Modelled | IHME |
| 0.96 (0.59 - 1.48) | 2017 | Modelled | IHME |
| 0.96 (0.59 - 1.47) | 2016 | Modelled | IHME |
| 0.96 (0.58 - 1.48) | 2015 | Modelled | IHME |
| 0.98 (0.59 - 1.49) | 2014 | Modelled | IHME |
| 0.98 (0.59 - 1.50) | 2013 | Modelled | IHME |
| 0.99 (0.60 - 1.50) | 2012 | Modelled | IHME |
| 1 (0.61 - 1.51) | 2011 | Modelled | IHME |
| 1.03 (0.64 - 1.52) | 2010 | Modelled | IHME |
| 1.05 (0.66 - 1.54) | 2009 | Modelled | IHME |
| 1.07 (0.67 - 1.58) | 2008 | Modelled | IHME |
| 1.1 (0.70 - 1.63) | 2007 | Modelled | IHME |
| 1.13 (0.73 - 1.65) | 2006 | Modelled | IHME |
| 1.15 (0.75 - 1.67) | 2005 | Modelled | IHME |
| 1.17 (0.77 - 1.69) | 2004 | Modelled | IHME |
| 1.2 (0.79 - 1.71) | 2003 | Modelled | IHME |
| 1.22 (0.81 - 1.75) | 2002 | Modelled | IHME |
| 1.23 (0.82 - 1.77) | 2001 | Modelled | IHME |
| 1.25 (0.84 - 1.79) | 2000 | Modelled | IHME |
| 1.25 (0.86 - 1.76) | 1999 | Modelled | IHME |
| 1.26 (0.86 - 1.78) | 1998 | Modelled | IHME |
| 1.26 (0.88 - 1.75) | 1997 | Modelled | IHME |
| 1.25 (0.87 - 1.77) | 1996 | Modelled | IHME |
| 1.25 (0.87 - 1.76) | 1995 | Modelled | IHME |
| 1.26 (0.87 - 1.77) | 1994 | Modelled | IHME |
| 1.27 (0.88 - 1.77) | 1993 | Modelled | IHME |
| 1.27 (0.88 - 1.76) | 1992 | Modelled | IHME |
| 1.28 (0.89 - 1.78) | 1991 | Modelled | IHME |
| 1.29 (0.91 - 1.80) | 1990 | Modelled | IHME |
Showing out of
Show more
HCV-related deaths
National
Download| Value | Year | Type | Source |
|---|---|---|---|
| 270 (168 - 417) | 2019 | Modelled | IHME |
| 268 (166 - 415) | 2018 | Modelled | IHME |
| 265 (162 - 406) | 2017 | Modelled | IHME |
| 256 (158 - 392) | 2016 | Modelled | IHME |
| 248 (151 - 385) | 2015 | Modelled | IHME |
| 246 (148 - 374) | 2014 | Modelled | IHME |
| 240 (144 - 365) | 2013 | Modelled | IHME |
| 233 (141 - 353) | 2012 | Modelled | IHME |
| 229 (139 - 344) | 2011 | Modelled | IHME |
| 226 (141 - 335) | 2010 | Modelled | IHME |
| 222 (140 - 327) | 2009 | Modelled | IHME |
| 218 (138 - 323) | 2008 | Modelled | IHME |
| 216 (137 - 321) | 2007 | Modelled | IHME |
| 214 (138 - 313) | 2006 | Modelled | IHME |
| 210 (137 - 304) | 2005 | Modelled | IHME |
| 206 (134 - 296) | 2004 | Modelled | IHME |
| 203 (134 - 289) | 2003 | Modelled | IHME |
| 199 (132 - 285) | 2002 | Modelled | IHME |
| 193 (128 - 277) | 2001 | Modelled | IHME |
| 188 (127 - 268) | 2000 | Modelled | IHME |
| 181 (124 - 255) | 1999 | Modelled | IHME |
| 176 (119 - 248) | 1998 | Modelled | IHME |
| 168 (118 - 235) | 1997 | Modelled | IHME |
| 161 (112 - 228) | 1996 | Modelled | IHME |
| 156 (108 - 219) | 1995 | Modelled | IHME |
| 151 (105 - 212) | 1994 | Modelled | IHME |
| 146 (102 - 204) | 1993 | Modelled | IHME |
| 142 (98 - 197) | 1992 | Modelled | IHME |
| 138 (96 - 191) | 1991 | Modelled | IHME |
| 134 (94 - 187) | 1990 | Modelled | IHME |
| 1,083 | 2016 | Modelled | WHO |
Showing out of
Show more
Percent of liver cancer deaths attributable to HCV
National
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 14 (10 - 20) | 2019 | Modelled | IHME |
| 14 (10 - 20) | 2018 | Modelled | IHME |
| 14 (10 - 20) | 2017 | Modelled | IHME |
| 14 (10 - 20) | 2016 | Modelled | IHME |
| 14 (10 - 20) | 2015 | Modelled | IHME |
| 14 (10 - 20) | 2014 | Modelled | IHME |
| 14 (10 - 20) | 2013 | Modelled | IHME |
| 14 (10 - 19) | 2012 | Modelled | IHME |
| 14 (9 - 19) | 2011 | Modelled | IHME |
| 14 (9 - 19) | 2010 | Modelled | IHME |
| 14 (10 - 19) | 2009 | Modelled | IHME |
| 14 (10 - 19) | 2008 | Modelled | IHME |
| 14 (10 - 19) | 2007 | Modelled | IHME |
| 14 (10 - 20) | 2006 | Modelled | IHME |
| 14 (10 - 20) | 2005 | Modelled | IHME |
| 14 (10 - 20) | 2004 | Modelled | IHME |
| 14 (10 - 20) | 2003 | Modelled | IHME |
| 14 (10 - 20) | 2002 | Modelled | IHME |
| 14 (10 - 20) | 2001 | Modelled | IHME |
| 14 (10 - 20) | 2000 | Modelled | IHME |
| 15 (10 - 20) | 1999 | Modelled | IHME |
| 15 (10 - 20) | 1998 | Modelled | IHME |
| 15 (10 - 20) | 1997 | Modelled | IHME |
| 15 (10 - 21) | 1996 | Modelled | IHME |
| 15 (10 - 21) | 1995 | Modelled | IHME |
| 15 (10 - 21) | 1994 | Modelled | IHME |
| 16 (10 - 22) | 1993 | Modelled | IHME |
| 16 (11 - 22) | 1992 | Modelled | IHME |
| 16 (11 - 22) | 1991 | Modelled | IHME |
| 16 (11 - 22) | 1990 | Modelled | IHME |
Showing out of
Show more
Number of needles/syringes per PWID per year
People who inject drugs (PWID)
Download| Value | Year | Type | Source |
|---|---|---|---|
| 0 (0 - 0) | 2016 | Survey/reported | Harm Reduction International, 2016 |
Percent of PWID accessing OST
People who inject drugs (PWID)
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 0 | 2016 | Survey/reported | Harm Reduction International, 2016 |
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
No
Eligible for HBV generic medicines
Overview
HBV elimination goal
HCV elimination goal
Prevalence (national)
Modelled
Survey/surveillance
No data available
Hepatitis related deaths (national)
Prevalence < 5
HBV
1.02
(%)
2019, latest modelled
(0.84 - 1.22(%))
IHME
Prevalence PWID
No data available
Birth dose vaccination coverage (national)
Survey/surveillance
No data available
Eligible for HBV generic medicines
Eligible for HCV generic medicines